Xtant Medical Holdings Inc. Announces Strategic Sale of Spinal Implant Assets
In a significant move within the healthcare sector, Xtant Medical Holdings Inc., a company specializing in health care equipment and supplies, has announced the sale of its spinal implant assets to Companion Spine, LLC. This transaction marks a pivotal shift in Xtant’s strategic focus, allowing the company to concentrate on its core businesses.
Transaction Details
On July 8, 2025, Xtant Medical Holdings disclosed that it had entered into definitive agreements to sell its Coflex® and CoFix® spinal implants, along with all overseas entities of Paradigm Spine GmbH, to Companion Spine. The transaction is valued at approximately $19.2 million. This sale is expected to bolster Xtant’s financial position by reducing outstanding debt and enhancing liquidity.
Companion Spine, a French-American company dedicated to posterior dynamic spine stabilization and motion preservation systems, is a portfolio company of Viscogliosi Brothers, LLC. This acquisition aligns with Companion Spine’s strategic goal to strengthen its global leadership in spine stabilization and motion preservation.
Strategic Implications
The sale is anticipated to facilitate Xtant Medical’s enhanced focus on its core areas, potentially leading to more robust growth and innovation in its primary markets. By divesting its spinal implant assets, Xtant aims to streamline operations and allocate resources more effectively towards its other regenerative surgical products.
Market Reaction
As of July 6, 2025, Xtant Medical’s stock was trading at $0.67, with a 52-week range between $0.33 and $0.83. The market capitalization stood at approximately $96.38 million. The company’s price-to-earnings ratio was reported at -7.76, reflecting its current financial challenges.
Future Outlook
The completion of the acquisition is expected in the third quarter of 2025. This strategic divestiture is likely to be viewed positively by investors, as it positions Xtant Medical to focus on its strengths and improve its financial health. The transaction underscores a forward-looking approach, aiming to enhance shareholder value through strategic realignment.
For more information on Xtant Medical Holdings and its offerings, interested parties can visit their website at www.xtantmedical.com . The company remains listed on the NYSE American exchange, continuing its journey in the health care equipment and supplies sector.